Internal Medicine, Gastroenterology · Chicago, IL
NPI
1649373903
Since 2006
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
676 N. Saint Clair Street, Suite 1400
Chicago, IL, 60611
Phone (857) 891-1575
Groups this clinician bills Medicare through
Medicare paid, 2024
$23K
260 services
Medicare patients, 2024
96
Average age 69
Drug cost, 2024
$3.1M
558 prescriptions
Company payments, 2025
$73.72
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Laura Yun was code 99215 (office e&m - established), 53 times for 35 patients. In total Laura Yun billed 260 services in 22 codes, and Medicare paid $23K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2009-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 53 | 35 | $116.73 | $6,186 |
| 45380 Lower GI Endoscopy - Other | Facility | 40 | 38 | $128.65 | $5,146 |
| 99214 Office E&M - Established | Facility | 27 | 23 | $72.86 | $1,967 |
| G0500 Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 24 | 23 | $5.66 | $136 |
| 99213 Office E&M - Established | Facility | 13 | 11 | $56.04 | $729 |
| 45385 Colonoscopy - Lesion Removal | Facility | 12 | 12 | $219.56 | $2,635 |
By year: 2022 $22K for 223 services; 2023 $21K for 225 services; 2024 $23K for 260 services.
Medicare prescription drug claims, 2024
In 2024, the drug Laura Yun prescribed most often to Medicare patients was Mesalamine, with 95 prescriptions and refills. In total Laura Yun wrote 558 Medicare prescriptions that cost $3.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Mesalamine Generic | 95 | 260 | 27 | $93K |
| Stelara Ustekinumab | 71 | 78 | Under 11 | $1.9M |
| Humira(Cf) Pen Adalimumab | 31 | 31 | Under 11 | $441K |
| Omeprazole Generic | 29 | 85 | Under 11 | $758 |
| Sulfasalazine Generic | 29 | 81 | Under 11 | $1,505 |
| Mercaptopurine Generic | 25 | 73 | Under 11 | $3,429 |
| Loperamide Loperamide Hcl | 23 | 37 | Under 11 | $2,610 |
| Peg 3350-Electrolyte Sodium Chloride/Nahco3/Kcl/Peg | 23 | 23 | 22 | $367 |
| Pantoprazole Sodium Generic | 20 | 50 | Under 11 | $328 |
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 20 | 20 | 19 | $1,368 |
| Cholestyramine Cholestyramine (With Sugar) | 20 | 44 | Under 11 | $1,226 |
| Skyrizi On-Body Risankizumab-Rzaa | 19 | 31 | Under 11 | $379K |
| Azathioprine Generic | 18 | 52 | Under 11 | $3,545 |
| Renflexis Infliximab-Abda | 13 | 13 | Under 11 | $36K |
Brand drugs: 242 claims; generic drugs: 316 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Laura Yun $73.72 ($73.72 in general payments such as food, travel and fees) from 3 companies. The largest payer was Abbvie Inc. with $31.19.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.